FBI issues safety warning about counterfeit versions of weight loss drug semaglutide
Wegovy contains the same main ingredient as Ozempic, semaglutide, and is FDA-approved for weight loss in people with obesity or who are overweight with at least one weight-related condition. It is ...
The FDA Cracking Down on Compounded Weight Loss Drugs – Here’s What It Means for Telehealth Companies and Consumers
After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...
Millions of people are taking compounded weight loss drugs. Now they're about to disappear.
Compounded GLP-1s have given rise to a cottage industry offering cheaper weight loss medications to many Americans — but now ...
These discounted versions of popular weight-loss drugs are going away: What to know
Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...
Compound versions of some weight loss drugs to be restricted
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...
FBI gives new warning about fake weight loss drugs being sold in Georgia
The federal agency’s new alert is about counterfeit drugs claiming to have semaglutide — the key ingredient in weight loss ...
Access to Compounded GLP-1s Is Drying Up. Here’s What to Know About the Copycat Weight-Loss Drugs.
This story mentions weight, weight loss, and/or GLP-1 drugs. In the last few years, GLP-1s, prescription weight loss ...
US FDA to Hold off Action on Weight-Loss Drug Copies Pending Court Ruling
In its Monday update, the FDA clarified that state-licensed compounding pharmacies and outsourcing facilities — which make ...
Chemistry World3d
Ending of US weight-loss drug shortages prompts compounder complaints
Novo Nordisk’s semaglutide diabetes and weight loss drugs, Ozempic and Wegovy, are no longer officially in shortage in the US ...
Analysts Have Mixed Reviews on Hims & Hers Stock Amid Uncertainty Around Weight Loss Business
Telehealth company Hims & Hers Health (HIMS) witnessed a major dip in its stock recently despite reporting 95% revenue growth ...
AOL3d
Compound versions of some weight loss drugs to be restricted
Most compounded versions of popular ... thereby causing weight loss. Some people are overdosing on semaglutide, FDA warns Ozempic is approved by the FDA to treat Type 2 diabetes, but some doctors ...
Detroit Free Press13d
These discounted versions of popular weight-loss drugs are going away: What to know
Consumers will have a bit longer to get compounded semaglutide, which is sold under the brands Wegovy for weight loss and Ozempic for diabetes. In December, the FDA declared Eli Lilly's ...